{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:53:04Z","timestamp":1771048384826,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL139671-01"],"award-info":[{"award-number":["HL139671-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG R21AG058348"],"award-info":[{"award-number":["AG R21AG058348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007261","name":"New York Academy of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","award":["AG K24AG036778"],"award-info":[{"award-number":["AG K24AG036778"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cardfail.2021.12.016","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T11:55:10Z","timestamp":1640865310000},"page":"950-959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis"],"prefix":"10.1016","volume":"28","author":[{"given":"Jaya","family":"Batra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan M.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil E.","family":"Saith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffeny","family":"De Los Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Argiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-5008","authenticated-orcid":false,"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2021.12.016_bib0001","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0002","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0003","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0005","first-page":"1","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"00","author":"Damy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0006","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mgg3.231","article-title":"The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa","volume":"4","author":"Jacobson","year":"2016","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2459\/JCM.0000000000000290","article-title":"The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience","volume":"17","author":"Cappelli","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0008","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13506120802193720","article-title":"Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population","volume":"15","author":"Hellman","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaccao.2020.06.007","article-title":"Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis","volume":"2","author":"Cheng","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0011","first-page":"1091","article-title":"ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"16","author":"Cheitlin","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Card"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0013","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0002-9149(96)00425-0","article-title":"Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography","volume":"78","author":"de Simone","year":"1996","journal-title":"Am J Card"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0014","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.amjcard.2016.11.048","article-title":"Relation of the myocardial contraction fraction, as calculated from M-mode echocardiography, with incident heart failure, atherosclerotic cardiovascular disease, and mortality (results from the Cardiovascular Health Study)","volume":"119","author":"Maurer","year":"2017","journal-title":"Am J Card"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455","article-title":"Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS)","volume":"4","author":"Bhuiyan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0016","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCIMAGING.113.000690","article-title":"Size matters! Impact of age, sex, height, and weight on the normal heart size","volume":"6","author":"Pfaffenberger","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0017","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0735-1097(01)01651-5","article-title":"Noninvasive single-beat determination of left ventricular end-systolic elastance in humans","volume":"38","author":"Chen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0018","doi-asserted-by":"crossref","first-page":"H403","DOI":"10.1152\/ajpheart.01240.2005","article-title":"Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application","volume":"291","author":"Klotz","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0019","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.86.2.513","article-title":"Effective arterial elastance as index of arterial vascular load in humans","volume":"86","author":"Kelly","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02058751","article-title":"Systolic pressure-volume area (PVA) as the energy of contraction in Starling's law of the heart","volume":"6","author":"Suga","year":"1991","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0021","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurheartj\/ehz748.1048","article-title":"P2731 genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene","volume":"40","author":"Cappelli","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0022","series-title":"Health, United States, 2018","year":"2019"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0023","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","article-title":"Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis","volume":"168","author":"Bahrami","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchf.2016.10.011","article-title":"Race-related differences in left ventricular structural and functional remodeling in response to increased afterload: the ARIC study","volume":"5","author":"Fernandes-Silva","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0025","doi-asserted-by":"crossref","first-page":"3i","DOI":"10.1016\/j.amjcard.2005.07.028","article-title":"Heart failure in African Americans","volume":"96","author":"Yancy","year":"2005","journal-title":"Am J Card"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0026","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199902253400804","article-title":"Racial differences in the outcome of left ventricular dysfunction","volume":"340","author":"Dries","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ajh.2011.182","article-title":"The ACE I\/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race\/ethnicity","volume":"25","author":"Ned","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cardfail.2021.12.016_bib0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.HYP.37.1.46","article-title":"Interactive effect of ethnicity and ACE insertion\/deletion polymorphism on vascular reactivity","volume":"37","author":"Gainer","year":"2001","journal-title":"Hypertension"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421005273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421005273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:46:42Z","timestamp":1761029202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916421005273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1071916421005273"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.12.016","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}